IS
IS · IS · IS-EU/1/16/1146/010-018
Glyxambi
ATC A10BD19
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerBoehringer Ingelheim International GmbH*
CountryIS (IS)
ATC codeA10BD19
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "A10BD19",
"marketed": false,
"strength": "25 mg/5 mg",
"ma_number": "EU/1/16/1146/010-018",
"substance": "Empagliflozinum INN,Linagliptinum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "42685"
}Related drugs
Other records sharing ATC code A10BD19.
- NOGlyxambiBoehringer Ingelheim International GmbH
- 🇨🇭Glyxambi
- PLGlyxambiBoehringer Ingelheim International GmbH
- PLGlyxambiBoehringer Ingelheim International GmbH
- 🇨🇭GlyxambiBoehringer Ingelheim (Schweiz) GmbH
- DKGlyxambiBoehringer Ingelheim Int. GmbH
- ISGlyxambiBoehringer Ingelheim International GmbH*
- NOGlyxambiBoehringer Ingelheim International GmbH
Access this data programmatically
Query Glyxambi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.